A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
about
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsDrugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisAntioxidant supplements for liver diseasesAntioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesAntioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitisDrugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisNonalcoholic fatty liver disease: a comprehensive review of a growing epidemicMetabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential linkNonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and managementTreatment of non-alcoholic fatty liver diseaseTreatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directionsA Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDManagement of non-alcoholic fatty liver disease in 2015The therapy of insulin resistance in other diseases besides type 2 diabetesPathophysiology guided treatment of nonalcoholic steatohepatitisMultiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)Hepatic steatosis and Type 2 diabetes: current and future treatment considerations.Vitamin E and nonalcoholic fatty liver diseaseMetformin and metabolic diseases: a focus on hepatic aspectsMitochondrial Trifunctional Protein Defects: Clinical Implications and Therapeutic ApproachesPerspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future TherapiesMediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection.Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography.Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic review.Pathogenesis of non-alcoholic fatty liver disease.Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-β-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 CellVitamin E and all-cause mortality: a meta-analysis.Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control studyTreatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus.Metformin ameliorates hepatic steatosis and improves the induction of autophagy in HFD‑induced obese mice.Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas.Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management.Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver diseaseFructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitisTreatment options for nonalcoholic Fatty liver diseaseManagement of nonalcoholic fatty liver disease: an evidence-based clinical practice review.
P2860
Q22299426-BD235C33-E8AF-4026-AF1C-83075991CA6EQ24197984-AA52812E-1C97-445E-AAFB-2B961F9CE34EQ24235796-86D57F2D-894C-43BE-8AAF-23293E747FD0Q24242944-801699C8-58A8-49FB-B3C1-994F72493C5EQ24243125-15394265-1E84-49E3-AE62-C275BB0ACF3EQ24246447-3A81B2B8-65C4-4BC9-9B7C-345DA7FFD3D0Q24563381-7C605198-D28B-4E74-9219-4E4694D3CB12Q24631619-F660CF8F-EC24-409F-BD6A-C671533446B5Q24649618-2B973630-2B8B-4F29-8953-B64577D12885Q24655572-58194FF0-318B-4E6D-BD57-10D62E79E0ACQ26751258-F857190B-56A5-4EDF-B9A8-1D186BE57E9BQ26752487-A07D8C4E-CF06-4AD9-854C-6EFEC93415C5Q26771148-DD50F313-7848-4386-BF97-7918BD20F16BQ26822399-2F507BE1-3078-4F04-A21A-1CBB037B1B95Q26827117-A5B1E027-5170-4C8E-80D6-7D5F331A7C56Q27007515-89235D6B-C767-4485-A02E-8304B48CC1DFQ27691399-C5296591-CFFE-43E2-BA9B-44DAF6DE1592Q27693883-4384342B-5089-4948-BA83-5EB85786A0DDQ28082736-7FEBB251-5FAE-4906-9608-A4436EAF7530Q28972544-58B292BD-BC9B-46C5-A1B0-387ABE5E0C22Q30234444-82E90003-A317-4928-B77B-D7B7B65F9D3CQ30248650-946009F5-2A7B-44F9-8889-D78DA46EC5CFQ30389752-EA0B0A6A-56E4-4FFA-AAD3-6B43B0905A6FQ30401022-0301B730-4F53-4784-83D5-08E6894A4923Q30467234-82BB1C45-4D0B-4BAF-8E69-D4C0D9250735Q33268183-19692BCF-15B4-41FC-AFD9-E7DE9B45997EQ33606303-0297A291-8638-4F02-98E6-FB4649FC5BCBQ33647291-F8A9A6E5-7AC8-4E57-A15A-026D5E71434FQ33649141-A5E111DF-1B53-41D4-A7F3-9DE4F85B62BAQ33687762-CE08C9FB-EF19-465D-9B35-14340D69599FQ33802278-B3564128-40D8-4036-9D22-CC6E989F5878Q33828153-450DBCF8-C4B9-4119-8A10-206E9641B859Q33867088-490E3F44-18FC-4DBE-88A6-06A1E8A2C96BQ33879548-6F20F924-BCD1-49CF-8561-F6C6AAA031CAQ33891750-C59EDC15-BDF8-4FBE-B5F0-B6801DDCEC99Q33909796-DE8EEE19-36C9-4FB8-91E8-1B7D522137DFQ34056163-5E318A80-923E-4CF7-9164-BB69E1BCDDE0Q34130429-0F49808D-9C55-4E6C-B3F6-4EC13920795DQ34156317-252AD2C9-9968-4757-BE60-FD7D47538047Q34168532-F4DAEBED-FB9F-4AA7-8137-5EA1662D561C
P2860
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A randomized controlled trial ...... alcoholic fatty liver disease.
@en
A randomized controlled trial ...... alcoholic fatty liver disease.
@nl
type
label
A randomized controlled trial ...... alcoholic fatty liver disease.
@en
A randomized controlled trial ...... alcoholic fatty liver disease.
@nl
prefLabel
A randomized controlled trial ...... alcoholic fatty liver disease.
@en
A randomized controlled trial ...... alcoholic fatty liver disease.
@nl
P2093
P2860
P1476
A randomized controlled trial ...... alcoholic fatty liver disease.
@en
P2093
Elena Gentilcore
Ester Vanni
Ezio David
Mario Rizzetto
Nicola Villanova
Rita Manini
Stefania Natale
P2860
P304
P356
10.1111/J.1572-0241.2005.41583.X
P407
P577
2005-05-01T00:00:00Z